Shares of Bellerophon Therapeutics, Inc. (BLPH) are rising more than 25% at $2.39.
The company today announced into a subscription agreement with a life sciences-focused institutional investor to sell 718,474 shares at a price of $2.00 per share and 1,781,526 prefunded warrants at $1.99 per pre-funded warrant.
The company intends to use the proceeds of about$5 million from this offering to complete its Phase 3 REBUILD study of inhaled nitric oxide (iNO) in patients at risk for pulmonary hypertension, and for working capital and general corporate purposes.
The offering is expected to close on March 7.
BLPH has traded in the range of $0.67-$3.50 in the last 1 year.
Source: Read Full Article
Lates News:
-
State Street Corp. Adds 10% On Additional Share Repurchase
-
$BTC: 3.4 Million Bitcoin Addresses Buy The Dip After Price Drops Below $30,000, Data Shows
-
Why Max Keiser Is Highly Optimistic About Bitcoin Cracking $220,000 In ‘A Flash’
-
Dormant Bitcoin ($BTC) Supply Hits New All-Time High as Market 'Stress Tests' Weaker Hands
-
MicroStrategy's Michael Saylor Signals Elon Musk to Purchase More Bitcoin